Up-regulation of CTD-2547G23.4 in Hepatocellular Carcinoma Tissues and Its Prospective Molecular Regulatory Mechanism: a Novel QRT-PCR and Bioinformatics Analysis Study

Overview

Journal Cancer Cell Int

Publisher Biomed Central

Date 2018 May 22

PMID 29780284

Citations 8

Authors

Dong-Yue Wen

Peng Lin

Hai-Wei Liang

Xia Yang

Hai-Yuan Li

Yun He

Hong Yang

Gang Chen

Affiliations

Soon will be listed here.

Abstract

Background: Dysregulated expression of long non-coding RNAs (lncRNAs) has been reported in the pathogenesis and progression of multiple cancers, including hepatocellular carcinoma (HCC). LncRNA CTD-2547G23.4 is a novel lncRNA, and its role in HCC is still unknown. Here, we aimed to clarify the expression pattern and clinical value of CTD-2547G23.4 and to investigate the prospective regulatory mechanism via bioinformatics analysis in HCC.

Methods: To identify differentially expressed lncRNAs in HCC, we downloaded RNA-Seq data for HCC and adjacent non-tumour tissues via The Cancer Genome Atlas (TCGA). CTD-2547G23.4 was selected by using the R language and receiver operating characteristic curve analysis. Furthermore, we validated the differential expression of CTD-2547G23.4 via Gene Expression Omnibus (GEO), ArrayExpress, Oncomine databases and quantitative real-time polymerase chain reaction (qRT-PCR). The relationship between the CTD-2547G23.4 level and clinic pathological parameters was also assessed. To further probe the role of CTD-2547G23.4 in HCC cell cycle, lentivirus-mediated small interfering RNA was applied to silence CTD-2547G23.4 expression in Huh-7 cell line. In addition, the related genes of CTD-2547G23.4 gathered from The Atlas of Noncoding RNAs in Cancer (TANRIC) database and Multi Experiment Matrix (MEM) were assessed with Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes, Protein Analysis Through Evolutionary Relationships and protein-protein interaction (PPI) networks.

Results: CTD-2547G23.4 expression was remarkably higher in 370 HCC tissue samples than that in adjacent non-tumour liver tissues (48.762 ± 27.270 vs. 14.511 ± 8.341, P < 0.001) from TCGA dataset. The relative expression level of CTD-2547G23.4 in HCC was consistently higher than that in adjacent non-cancerous tissues (2.464 ± 0.833 vs. 1.813 ± 0.784, P = 0.001) as assessed by real time RT-qPCR. The area under the curve of the summary receiver operating characteristic curve was 0.8720 based on TCGA, qRT-PCR and GEO data. Further analysis indicated that the increased expression levels of CTD-2547G23.4 were associated with the neoplasm histologic grade and vascular tumour cell type. The expression of CTD-2547G23.4 was significantly downregulated in CTD-2547G23.4 knockdown cells. Moreover, cell cycle analysis revealed that CTD-2547G23.4 depletion in Huh-7 cell line led to S phase arrest. Furthermore, 314 related genes identified by TANRIC and MEM databases were processed with a pathway analysis. The bioinformatics analysis indicated that CTD-2547G23.4 might play a key role in the progress of HCC through four hub genes, SRC, CREBBP, ADCY8 and PPARA.

Conclusions: Collectively, we put forward the hypothesis that the novel lncRNA CTD-2547G23.4 may act as an exceptional clinical index and promote the HCC tumourigenesis and progression via various related genes.

Citing Articles

Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy.

Guo R, Liu T, Shasaltaneh M, Wang X, Imani S, Wen Q Front Oncol. 2022; 12:829212.

PMID: 35832555 PMC: 9271773. DOI: 10.3389/fonc.2022.829212.

N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.

Song W, Ren J, Yuan W, Xiang R, Ge Y, Fu T Genes (Basel). 2021; 12(9).

PMID: 34573357 PMC: 8472391. DOI: 10.3390/genes12091375.

Identification of a Novel Metastasis-Related miRNAs-Based Signature for Predicting the Prognosis of Hepatocellular Carcinoma.

Chen Y, Wang G, Xu H, Wang H, Bai D J Oncol. 2021; 2021:6629633.

PMID: 33603784 PMC: 7870303. DOI: 10.1155/2021/6629633.

Clinical significance of miR-1180-3p in hepatocellular carcinoma: a study based on bioinformatics analysis and RT-qPCR validation.

Zhou Z, Zhou X, Jiang Y, Qiu M, Liang X, Lin Q Sci Rep. 2020; 10(1):11573.

PMID: 32665670 PMC: 7360737. DOI: 10.1038/s41598-020-68450-z.

Overexpression of MiR-452-5p in hepatocellular carcinoma tissues and its prospective signaling pathways.

Rong M, Cai K, Lu H, Guo Y, Huang X, Zhu Z Int J Clin Exp Pathol. 2020; 12(11):4041-4056.

PMID: 31933800 PMC: 6949781.

References

Xie H, Ma H, Zhou D . Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma. Biomed Res Int. 2013; 2013:136106. PMC: 3674644. DOI: 10.1155/2013/136106. View

Zhao R, Tin L, Zhang Y, Wu Y, Jin Y, Jin X . EF24 Suppresses Invasion and Migration of Hepatocellular Carcinoma Cells via Inhibiting the Phosphorylation of Src. Biomed Res Int. 2016; 2016:8569684. PMC: 5141541. DOI: 10.1155/2016/8569684. View

Jia Q, Dong Q, Qin L . CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma?. Oncotarget. 2015; 7(2):1203-14. PMC: 4811454. DOI: 10.18632/oncotarget.6209. View

Frame M . Src in cancer: deregulation and consequences for cell behaviour. Biochim Biophys Acta. 2002; 1602(2):114-30. DOI: 10.1016/s0304-419x(02)00040-9. View

Lv J, Fan H, Zhao X, Lv P, Fan J, Zhang Y . Long non-coding RNA Unigene56159 promotes epithelial-mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cells. Cancer Lett. 2016; 382(2):166-175. DOI: 10.1016/j.canlet.2016.08.029. View

Li J, Luo J, Lu J, Liang X, Luo Y, Liu Y . Relationship between TRAF6 and deterioration of HCC: an immunohistochemical and in vitro study. Cancer Cell Int. 2016; 16:76. PMC: 5041287. DOI: 10.1186/s12935-016-0352-z. View

Tamura S, Kato T, Berho M, Misiakos E, OBrien C, Reddy K . Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg. 2001; 136(1):25-30; discussion 31. View

Li H, Yang H, Wen D, Luo Y, Liang C, Pan D . Overexpression of LncRNA HOTAIR is Associated with Poor Prognosis in Thyroid Carcinoma: A Study Based on TCGA and GEO Data. Horm Metab Res. 2017; 49(5):388-399. DOI: 10.1055/s-0043-103346. View

Drakaki A, Hatziapostolou M, Polytarchou C, Vorvis C, Poultsides G, Souglakos J . Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway. BMC Cancer. 2015; 15:542. PMC: 4512159. DOI: 10.1186/s12885-015-1562-9. View

10.

Li J, Han L, Roebuck P, Diao L, Liu L, Yuan Y . TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer. Cancer Res. 2015; 75(18):3728-37. PMC: 4573884. DOI: 10.1158/0008-5472.CAN-15-0273. View

11.

Vitale A, Peck-Radosavljevic M, Giannini E, Vibert E, Sieghart W, Van Poucke S . Personalized treatment of patients with very early hepatocellular carcinoma. J Hepatol. 2016; 66(2):412-423. DOI: 10.1016/j.jhep.2016.09.012. View

12.

Siegel R, Miller K, Jemal A . Cancer Statistics, 2017. CA Cancer J Clin. 2017; 67(1):7-30. DOI: 10.3322/caac.21387. View

13.

Liu J, Lu C, Xiao M, Jiang F, Qu L, Ni R . Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition. Biomed Pharmacother. 2017; 89:857-863. DOI: 10.1016/j.biopha.2017.01.011. View

14.

Tao Y, Hu K, Tan F, Zhang S, Zhou M, Luo J . SH3-domain binding protein 1 in the tumor microenvironment promotes hepatocellular carcinoma metastasis through WAVE2 pathway. Oncotarget. 2016; 7(14):18356-70. PMC: 4951293. DOI: 10.18632/oncotarget.7786. View

15.

Zhao S, Li H, Wang Q, Su C, Wang G, Song H . The role of c-Src in the invasion and metastasis of hepatocellular carcinoma cells induced by association of cell surface GRP78 with activated α2M. BMC Cancer. 2015; 15:389. PMC: 4455704. DOI: 10.1186/s12885-015-1401-z. View

16.

Sun C, Man K, Ng K, Ho J, Lim Z, Cheng Q . Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation. Carcinogenesis. 2008; 29(11):2096-105. DOI: 10.1093/carcin/bgn203. View

17.

He R, Gao L, Ma J, Peng Z, Zhou S, Yang L . The essential role of MTDH in the progression of HCC: a study with immunohistochemistry, TCGA, meta-analysis and investigation. Am J Transl Res. 2017; 9(4):1561-1579. PMC: 5411909. View

18.

Zhou M, Zhang X, Yu X . Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma. Biomed Pharmacother. 2016; 85:348-354. DOI: 10.1016/j.biopha.2016.11.035. View

19.

Zheng C, Hao H, Chen L, Shao J . Long noncoding RNAs as novel serum biomarkers for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Clin Transl Oncol. 2017; 19(8):961-968. DOI: 10.1007/s12094-017-1626-1. View

20.

Adler P, Kolde R, Kull M, Tkachenko A, Peterson H, Reimand J . Mining for coexpression across hundreds of datasets using novel rank aggregation and visualization methods. Genome Biol. 2009; 10(12):R139. PMC: 2812946. DOI: 10.1186/gb-2009-10-12-r139. View